Chih-Ying Lee,Hsiu-Ju Yen,Ming-Hsin Hou,Giun-Yi Hung,Cheng-Yin Ho,Ting-Yen Yu,Po-Kuei Wu,Chao-Ming Chen,Chueh-Chuan Yen,Cheng-Ying Shiau,Paul Chih-Hsueh Chen,Hung-Ta Hondar Wu,Ching-Lan Wu,Wei-Ming Chen

Abstract:A combination treatment of surgery, chemotherapy, and radiotherapy can improve the survivals of pediatric patients with Ewing sarcoma (ES). However, prognosis remains poor for patients with metastatic disease at diagnosis or recurrence. Other high-risk (HR) features include large tumor burden, tumors of the axial skeleton and poor histologic response. Several studies have documented high dose chemotherapy with autologous stem cell rescue (HDC-ASCR) to be effective in such patients. In this retrospective study, we present the results of HDC-ASCR for high-risk Ewing sarcoma in children and young adults in a single institute.

High dose chemotherapy with autologous stem cell rescue in children and young adults with high-risk Ewing sarcoma: A single institute experience in Taiwan